NeurAxis (NRXS) News Today $2.48 +0.06 (+2.48%) Closing price 03:59 PM EasternExtended Trading$2.65 +0.17 (+6.85%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NRXS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Short Interest in NeurAxis, Inc. (NASDAQ:NRXS) Grows By 85.6%August 20, 2025 | americanbankingnews.comNeurAxis, Inc. Reports Robust Q2 2025 GrowthAugust 13, 2025 | msn.comNeuraxis reports Q2 EPS (22c) vs. (42c) last yearAugust 12, 2025 | msn.comNeurAxis, Inc. (NRXS) Q2 2025 Earnings Call TranscriptAugust 12, 2025 | seekingalpha.comEarnings Outlook For NeuraxisAugust 11, 2025 | benzinga.comNeuraxis ends Masimo license agreement and launches employee stock planJuly 5, 2025 | investing.comNeurAxis, Inc. (NASDAQ:NRXS) Major Shareholder Acquires $800,001.00 in StockJuly 4, 2025 | insidertrades.comNeurAxis, Inc. Ends Agreement with Masimo CorporationJuly 3, 2025 | tipranks.comNeurAxis, Inc. (NRXS) Latest Stock News & Headlines - Yahoo FinanceJuly 2, 2025 | finance.yahoo.comNeurAxis, Inc. Expands Insurance Coverage for IB-Stim Therapy, Enhancing Access for Patients with Abdominal PainJune 17, 2025 | quiverquant.comQNeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered LivesJune 17, 2025 | globenewswire.comNeurAxis Achieves Critical Milestone; Secures Key Academic Society Guidelines Recommendation for Treatment of Functional Abdominal Pain (FAP) in IBSJune 10, 2025 | finance.yahoo.comNeurAxis, Inc. Announces Inclusion of PENFS Technology in Pediatric Gastroenterology Guidelines for Functional Abdominal Pain TreatmentJune 10, 2025 | quiverquant.comQNeurAxis, Inc. Approves Key Proposals at Annual MeetingJune 4, 2025 | tipranks.comNeurAxis, Inc. Completes $5 Million Registered Direct Offering to Support Growth of IB-Stim TherapyMay 22, 2025 | quiverquant.comQNeurAxis Announces Closing of $5.0 Million Registered Direct OfferingMay 22, 2025 | globenewswire.comNeurAxis, Inc. Announces $5 Million Stock OfferingMay 22, 2025 | tipranks.comNeurAxis, Inc. Receives $1 Million from Warrant ExercisesMay 21, 2025 | tipranks.comNeurAxis Announces $5.0 Million Registered Direct OfferingMay 21, 2025 | finance.yahoo.comNeurAxis Announces $5.0 Million Registered Direct OfferingMay 21, 2025 | globenewswire.comNeuraxis Stock Price, Quotes and Forecasts | AMEX:NRXS | BenzingaMay 21, 2025 | benzinga.comNeurAxis Stock Doubles with FDA Clearance for IB-StimMay 21, 2025 | marketwatch.comNeurAxis Awarded First Ever FDA Clearance for the Treatment of Pediatric FAP/Functional Dyspepsia (FD) and Associated Nausea SymptomsMay 21, 2025 | finance.yahoo.comNeurAxis, Inc. Reports 39% Revenue Growth in Q1 2025 Amid Expansion of Neuromodulation TherapiesMay 14, 2025 | nasdaq.comNeurAxis, Inc. (NRXS) Q1 2025 Earnings Call TranscriptMay 14, 2025 | seekingalpha.comNeurAxis Earnings Call: Growth Amid ChallengesMay 12, 2025 | tipranks.comNeurAxis, Inc.: NeurAxis Reports Strong First Quarter 2025 Financial Results Driven by a 39% Growth in RevenuesMay 12, 2025 | finanznachrichten.deNeurAxis Reports Strong First Quarter 2025 Financial Results Driven by a 39% Growth in RevenuesMay 12, 2025 | globenewswire.comNeurAxis to Host First Quarter 2025 Results and Business Update Call on Monday, May 12, 2025May 5, 2025 | globenewswire.comNeurAxis, Inc. (NASDAQ:NRXS) Major Shareholder Brian Hannasch Acquires 18,065 SharesApril 24, 2025 | insidertrades.com🌱 Man arrested in Norcross on child porn chargesMarch 29, 2025 | msn.comNeurAxis, Inc. (NASDAQ:NRXS) Q4 2024 Earnings Call TranscriptMarch 22, 2025 | insidermonkey.comEarnings call transcript: Neuraxis Q4 2024 sees revenue growth, loss narrowsMarch 22, 2025 | uk.investing.comNeurAxis, Inc. Reports 43% Revenue Growth in Q4 2024 and Significant Milestones AchievedMarch 22, 2025 | nasdaq.comNeurAxis, Inc. (NRXS) Q4 2024 Earnings Call TranscriptMarch 20, 2025 | seekingalpha.comNeurAxis, Inc.: NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in RevenuesMarch 20, 2025 | finanznachrichten.deNeurAxis Better on Q4 ResultsMarch 20, 2025 | baystreet.caNeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in RevenuesMarch 20, 2025 | globenewswire.comNeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025March 12, 2025 | globenewswire.comNeurAxis Has Crafted An Inflection PointJanuary 25, 2025 | seekingalpha.comUPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple StatesJanuary 21, 2025 | globenewswire.comNeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple StatesJanuary 21, 2025 | globenewswire.comNeuraxis issues letter to shareholdersJanuary 13, 2025 | markets.businessinsider.comNeurAxis, Inc. CEO Brian Carrico Shares 2024 Achievements and Vision for 2025 in Shareholder LetterJanuary 13, 2025 | quiverquant.comQNeurAxis Inc. Issues Letter to ShareholdersJanuary 13, 2025 | globenewswire.comNeuraxis reports Q4 revenue $800,000, up 50% vs. last yearJanuary 8, 2025 | markets.businessinsider.comNeurAxis, Inc.: NeurAxis Inc. Announces Strong Preliminary Unaudited Fourth Quarter 2024 Results; Revenues Increased 50% Year-Over-YearJanuary 8, 2025 | finanznachrichten.deNeurAxis Inc. Announces Strong Preliminary Unaudited Fourth Quarter 2024 Results; Revenues Increased 50% Year-Over-YearJanuary 8, 2025 | finance.yahoo.comNeurAxis, Inc. Reports 50% Revenue Growth in 4Q24 and $3.7 Million Cash BalanceJanuary 8, 2025 | quiverquant.comQNeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025January 6, 2025 | globenewswire.com Get NeurAxis News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NRXS Media Mentions By Week NRXS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NRXS News Sentiment▼0.001.02▲Average Medical News Sentiment NRXS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NRXS Articles This Week▼01▲NRXS Articles Average Week Get the Latest News and Ratings for NRXS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for NeurAxis and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies TELA Bio News Safe Pro Group News Pulmonx News QT Imaging News PolyPid News EDAP TMS News Sensus Healthcare News Spectral AI News Daxor News IceCure Medical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NRXS) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeurAxis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeurAxis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access